1120499

Llorens Pharmaceuticals International Division, Inc. — FEI 3008468946

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 11, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)

Citations

IDCFRDescription
108621 CFR 211.22(b)Adequate lab facilities not available
110521 CFR 211.22(d)Procedures not in writing, fully followed
201721 CFR 211.188(b)(5)In-Process and Laboratory Control Results
440621 CFR 211.194(a)(2)Suitability of testing methods verified